MetLife's Income Statement Analysis: Revenue to Profit Breakdown
MetLife's Income Statement Analysis: Revenue to Profit Breakdown
|
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$63.33 B | $68.76 B | $66.90 B | $70.98 B | $76.13 B | $76.95 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$46.53 B | $49.03 B | $50.42 B | $50.94 B | $58.82 B | $55.10 B |
Gross Profit Revenue minus cost of revenue. |
|
$16.80 B | $18.79 B | $15.99 B | $70.98 B | $17.31 B | $21.85 B |
|
Operating Expense
Costs to run business. |
|
$8.28 B | $12.43 B | $13.83 B | $13.34 B | $12.39 B | $17.04 B |
Research and Development Investment in innovation. |
|
- | - | - | - | - | - |
|
Sales, General and Administrative
Selling and admin costs. |
|
$5.76 B | $5.86 B | $6.18 B | $5.99 B | $8.37 B | $3.07 B |
General and Administrative Corporate overhead costs. |
|
$5.76 B | $5.86 B | $6.18 B | $5.99 B | $8.37 B | $3.07 B |
Sales and Marketing Customer acquisition costs. |
|
- | - | - | - | - | - |
Other Expenses Other operating costs. |
|
$2.52 B | $6.57 B | $7.65 B | $7.34 B | $4.02 B | $13.96 B |
Operating Income Profit from operations. |
|
$9.44 B | $7.30 B | $3.21 B | $6.66 B | $4.92 B | $4.81 B |
|
Net Interest Income
Interest income minus expense. |
|
-$920.00 M | -$938.00 M | -$1.05 B | -$1.04 B | -$1.06 B | -$1.07 B |
Interest Income Income from investments. |
|
- | - | - | - | - | - |
Interest Expense Cost of borrowing. |
|
$920.00 M | $938.00 M | $1.05 B | $1.04 B | $1.06 B | $1.07 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
- | - | - | - | -$798.00 M | -$1.07 B |
Total Other Income (Net) Net non-operating items. |
|
-$920.00 M | -$938.00 M | -$1.05 B | -$1.04 B | -$266.00 M | - |
Income Before Tax Profit before taxes. |
|
$8.52 B | $6.36 B | $2.16 B | $5.62 B | $4.66 B | $4.81 B |
Income Tax Expense Taxes on income. |
|
$1.64 B | $1.06 B | $560.00 M | $1.18 B | $1.29 B | $1.20 B |
|
Net Income
Final profit. |
|
$6.86 B | $5.28 B | $1.58 B | $4.43 B | $3.34 B | $3.62 B |
Net Income From Continuing Operations Profit from core business. |
|
$6.88 B | $5.30 B | $1.60 B | $4.44 B | $3.37 B | $3.62 B |
Net Income From Discontinued Operations Profit/loss from sold units. |
|
- | - | - | - | - | - |
Other Adjustments to Net Income Additional accounting adjustments. |
|
- | - | - | - | - | - |
Net Income Deductions Reductions from net income. |
|
- | - | - | - | - | - |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$7.70 | $6.35 | $1.82 | $5.98 | $4.73 | $5.19 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$7.65 | $6.30 | $1.81 | $5.94 | $4.70 | $5.16 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
825.54 M | 779.10 M | 762.43 M | 689.21 M | 664.96 M | 652.00 M |
Diluted Average Shares Outst. Shares including dilution. |
|
869.40 M | 808.90 M | 762.43 M | 711.10 M | 664.96 M | 655.70 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$9.44 B | $7.30 B | $3.21 B | $6.66 B | $5.72 B | $5.88 B |
EBITDA Earnings before interest, tax, D&A. |
|
$10.13 B | $7.98 B | $3.93 B | $7.37 B | $5.72 B | $5.88 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$694.00 M | $673.00 M | $718.00 M | $714.00 M | - | - |
| Company Report |
MetLife's Assets vs Liabilities & Equity
| Loading balance sheet when needed... |
| Loading cash flow statement when needed... |
| Loading profitability metrics when needed... |





